Clinuvel Pharmaceuticals Value At Risk
| CLVLY Stock | | | USD 6.84 0.05 0.74% |
The Value At Risk indicator for Clinuvel Pharmaceuticals is constructed from normalized market data. All inputs reflect available trading data across supported markets. Clinuvel Pharmaceuticals has a market cap of 800.45 M, operating margin of 54.07%, ROE of 18.62%. Allocation context is available in
Trending Equities. The portfolio view reflects current allocation structure. The allocation shows a weighting toward Clinuvel Pharmaceuticals Ltd. The weighting is visible within the allocation breakdown. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in state.
Clinuvel Pharmaceuticals Ltd has current Value At Risk of
-5.37. Value At Risk (or VAR) is a statistical technique used to measure the level of financial risk of investment instrument over a specific time frame. It is a widely used measure of the risk of loss on a specific investing instrument.
Value At Risk | = | ER[a] x N | + | (Z-SCORE x STD x SQRT (N)) |
| = | -5.37 | |
Value At Risk Peers Comparison
Value At Risk Relative To Other Indicators
Clinuvel Pharmaceuticals Ltd is rated
below average in value at risk among leading competitors. It is currently under evaluation in maximum drawdown among leading competitors .
Value At Risk is used by risk managers in order to measure and control the level of risk which the firm undertakes. The risk manager job is to ensure that risks are not taken beyond the level at which the firm can absorb the losses of a probable worst outcome. VAR can be defined as the loss level that will not be exceeded with a certain confidence level during a certain period of time.
Compare Clinuvel Pharmaceuticals to Peers
Other Technical Indicators